Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
2 other identifiers
interventional
1,282
3 countries
283
Brief Summary
The purpose of this study is to determine the efficacy, safety, and tolerability of different doses of eluxadoline (JNJ-27018966) compared with placebo in the treatment of participants with diarrhea-predominant irritable bowel syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started May 2012
283 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2012
CompletedFirst Posted
Study publicly available on registry
March 14, 2012
CompletedStudy Start
First participant enrolled
May 29, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 29, 2014
CompletedResults Posted
Study results publicly available
September 4, 2018
CompletedSeptember 4, 2018
August 1, 2018
2.2 years
March 8, 2012
June 11, 2018
August 3, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of Participants Who Were Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain And Daily Stool Consistency Scores
Composite responders were defined as a participant who met the daily response criteria for at least 50% of the days with diary entries during the interval of interest. A participant must had met both of the following criteria on a given day to be a daily responder: 1) Daily pain response: worst abdominal pain scores in the past 24 hours improved by ≥30% compared to baseline (average of daily worst abdominal pain the week prior to randomization). 2) Daily stool consistency response: Bristol Stool Scale (BSS) score \<5 (ie, score of 1, 2, 3, or 4) or the absence of a bowel movement if accompanied by ≥30% improvement in worst abdominal pain compared to baseline pain. Bristol stool scale was defined as 7-point Scale in which a score of 1 = separate hard lumps, 2 = sausage shaped but lumpy, 3 = sausage-like with cracks on the surface, 4 = sausage-like but smooth and soft, 5 = soft blobs with clear cut edges, 6 = fluffy pieces with ragged edges, and 7 = watery with no solid pieces.
Up to 12 Weeks
Secondary Outcomes (14)
Percentage of Participants Who Were Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain And Daily Stool Consistency Scores
Up to 26 Weeks
Percentage of Participants Who Were Pain Responders In Daily Worst Abdominal Pain Scores by Intervals
12-week interval (Weeks 1-12), 26-week interval (Weeks 1-26), and 4-week interval (Weeks 1-4, 5-8, 9-12, 13-16, 17-20, and 21-24)
Percentage of Participants Who Were Responders In Daily Stool Consistency Scores by Intervals
12-week interval (Weeks 1-12), 26-week interval (Weeks 1-26), and 4-week interval (Weeks 1-4, 5-8, 9-12, 13-16, 17-20, and 21-24)
Percentage of Participants Who Were Responders In Irritable Bowel Syndrome, Diarrhea Predominant (IBS-d) Global Symptom Scale by Intervals
12-week interval (Weeks 1-12), 26-week interval (Weeks 1-26), and 4-week interval (Weeks 1-4, 5-8, 9-12, 13-16, 17-20, and 21-24)
Percentage of Participants Who Were Responders to the Irritable Bowel Syndrome Quality of Life Measure (IBS-QoL) Scale
Weeks 4, 8, 12, 18, 26, 36, 44, and 52 (End of Treatment [EOT])
- +9 more secondary outcomes
Study Arms (3)
Eluxadoline 75 mg
EXPERIMENTALEluxadoline 75 mg tablets, orally, twice daily for up to 52 weeks period.
Eluxadoline 100 mg
EXPERIMENTALEluxadoline 100 mg tablets, orally, twice daily for up to 52 weeks period.
Placebo
PLACEBO COMPARATOREluxadoline placebo matching tablets, orally, twice daily for up to 52 weeks period.
Interventions
Oral tablets twice daily
Eligibility Criteria
You may qualify if:
- Participant has a diagnosis of irritable bowel syndrome (IBS) with a subtype of diarrhea defined by the Rome III criteria.
- Participant has had a colonoscopy performed:
- Within 10 years prior to Prescreening if participant is at least 50 years of age (sigmoidoscopy, double contrast barium enema, or computed tomography (CT) colonography within the past 5 years is acceptable)
- Since the onset (if applicable) of any of the following alarm features for participants of any age:
- Participant has documented weight loss within the past 6 months
- Participant has nocturnal symptoms
- Participant has a familial history of first-degree relatives with colon cancer or
- Participant has blood mixed with their stool (excluding blood from hemorrhoids).
- Female participants must be:
- Postmenopausal, defined as 52 years or older and amenorrheic for at least 2 years at Prescreening,
- Surgically sterile (have had a hysterectomy or bilateral oophorectomy, tubal ligation, or otherwise be incapable of pregnancy),
- Abstinent, or
- If sexually active, be practicing an effective method of birth control.
You may not qualify if:
- Participant has a diagnosis of IBS with a subtype of constipation, mixed IBS, or unsubtyped IBS by the Rome III criteria.
- Participant has a history of inflammatory or immune-mediated gastrointestinal (GI) disorders including inflammatory bowel disease (ie, Crohn's disease, ulcerative colitis) and celiac disease.
- Participant has a history of diverticulitis within 3 months prior to Prescreening.
- Participant has a history of intestinal obstruction, stricture, toxic megacolon, GI perforation, fecal impaction, gastric banding, bariatric surgery, adhesions, ischemic colitis, or impaired intestinal circulation (eg, aortoiliac disease).
- Participant has any of the following surgical history:
- Cholecystectomy with any history of post cholecystectomy biliary tract pain
- Any abdominal surgery within the 3 months prior to Prescreening
- Participant has a history of major gastric, hepatic, pancreatic, or intestinal surgery (appendectomy, hemorrhoidectomy, or polypectomy greater than 3 months post surgery are allowed)
- Other protocol-specific eligibility criteria may apply.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (283)
Furiex Research Site
Athens, Alabama, 35611, United States
Furiex Research Site
Birmingham, Alabama, 35213, United States
Furiex Research Site
Foley, Alabama, 36535, United States
Furiex Research Site
Huntsville, Alabama, 35802, United States
Furiex Research Site
Ozark, Alabama, 36360, United States
Furiex Research Site
Chandler, Arizona, 85224, United States
Furiex Research Site
Glendale, Arizona, 85306, United States
Furiex Research Site
Mesa, Arizona, 85213, United States
Furiex Research Site
Phoenix, Arizona, 85018, United States
Furiex Research Site
Tucson, Arizona, 85712, United States
Furiex Research Site
Little Rock, Arkansas, 72211, United States
Furiex Research Site
Little Rock, Arkansas, 72212, United States
Furiex Research Site
North Little Rock, Arkansas, 72117, United States
Furiex Research Site
Azusa, California, 91702, United States
Furiex Research Site
Bell Gardens, California, 90201, United States
Furiex Research Site
Beverly Hills, California, 90211, United States
Furiex Research Site
Carson, California, 91105, United States
Furiex Research Site
Chula Vista, California, 91910, United States
Furiex Research Site
Corona, California, 92880, United States
Furiex Research Site
El Cajon, California, 92020, United States
Furiex Research Site
Encino, California, 91436, United States
Furiex Research Site
Garden Grove, California, 92843, United States
Furiex Research Site
Lomita, California, 90717, United States
Furiex Research Site
Los Angeles, California, 90022, United States
Furiex Research Site
Monterey Park, California, 91754, United States
Furiex Research Site
Murrieta, California, 92562, United States
Furiex Research Site
Newport Beach, California, 92663, United States
Furiex Research Site
North Hollywood, California, 91606, United States
Furiex Research Site
Oakland, California, 94612, United States
Furiex Research Site
Oxnard, California, 93030, United States
Furiex Research Site
Pismo Beach, California, 93449, United States
Furiex Research Site
Poway, California, 92064, United States
Furiex Research Site
Riverside, California, 92501, United States
Furiex Research Site
Roseville, California, 95661, United States
Furiex Research Site
Sacramento, California, 95825, United States
Furiex Research Site
San Diego, California, 92103, United States
Furiex Research Site
San Diego, California, 92114, United States
Furiex Research Site
Santa Monica, California, 90404, United States
Furiex Research Site
Thousand Oaks, California, 91360, United States
Furiex Research Site
Colorado Springs, Colorado, 80904, United States
Furiex Research Site
Colorado Springs, Colorado, 80907, United States
Furiex Research Site
Lafayette, Colorado, 80026, United States
Furiex Research Site
Lakewood, Colorado, 80215, United States
Furiex Research Site
Longmont, Colorado, 80501, United States
Furiex Research Site
Norwalk, Connecticut, 06851, United States
Furiex Research Site
Ridgefield, Connecticut, 06877, United States
Furiex Research Site
Boca Raton, Florida, 33428, United States
Furiex Research Site
Brandon, Florida, 33511, United States
Furiex Research Site
Clearwater, Florida, 33765, United States
Furiex Research Site
Cooper City, Florida, 33024, United States
Furiex Research Site
Coral Springs, Florida, 33065, United States
Furiex Research Site
Crystal River, Florida, 34429, United States
Furiex Research Site
Doral, Florida, 33172, United States
Furiex Research Site
Eustis, Florida, 32726, United States
Furix Research Site
Hialeah, Florida, 33013, United States
Furiex Research Site
Hialeah, Florida, 33016, United States
Furiex Research Site
Inverness, Florida, 34452, United States
Furiex Research Site
Jacksonville, Florida, 32216, United States
Furiex Research Site
Kissimmee, Florida, 34741, United States
Furiex Research Site
Maitland, Florida, 32751, United States
Furiex Research Site
Melbourne, Florida, 32935, United States
Furiex Research Site
Miami, Florida, 33015, United States
Furiex Research Site
Miami, Florida, 33125, United States
Furiex Research Site
Miami, Florida, 33126, United States
Furiex Research Site
Miami, Florida, 33133, United States
Furiex Research Site
Miami, Florida, 33135, United States
Furiex Research Site
Miami, Florida, 33144, United States
Furiex Research Site
Miami, Florida, 33155, United States
Furiex Research Site
Miami, Florida, 33175, United States
Furiex Research Site
Miami Springs, Florida, 33166, United States
Furiex Research Site
Miramar, Florida, 33025, United States
Furiex Research Site
Naples, Florida, 34102, United States
Furiex Research Site
New Port Richey, Florida, 34653, United States
Furiex Research Site
New Smyrna Beach, Florida, 32168, United States
Furiex Research Site
Orlando, Florida, 32801, United States
Furiex Research Site
Orlando, Florida, 32806, United States
Furiex Research Site
Orlando, Florida, 32819, United States
Furiex Research Site
Ormond Beach, Florida, 32174, United States
Furiex Research Site
Oviedo, Florida, 32765, United States
Furiex Research Site
Palm Beach, Florida, 33472, United States
Furiex Research Site
Pinellas Park, Florida, 33781, United States
Furiex Research Site
Pinellas Park, Florida, 33782, United States
Furiex Research Site
Port Orange, Florida, 32129, United States
Furiex Research Site
Sanford, Florida, 32771, United States
Furiex Research Site
Sebastian, Florida, 32958, United States
Furiex Research Site
South Miami, Florida, 33143, United States
Furiex Research Site
Tampa, Florida, 33606, United States
Furiex Research Site
Tampa, Florida, 33607, United States
Furiex Research Site
Venice, Florida, 34292, United States
Furiex Research Site
Wellington, Florida, 33414, United States
Furiex Research Site
Winter Haven, Florida, 33880, United States
Furiex Research Site
Winter Park, Florida, 32792, United States
Furiex Research Site
Atlanta, Georgia, 30338, United States
Furiex Research Site
Blue Ridge, Georgia, 30513, United States
Furiex Research Site
Johns Creek, Georgia, 30097, United States
Furiex Research Site
Lilburn, Georgia, 30047, United States
Furiex Research Site
Oakwood, Georgia, 30566, United States
Furiex Research Site
Perry, Georgia, 31069, United States
Furiex Research Site
Snellville, Georgia, 30078, United States
Furiex Research Site
Eagle, Idaho, 83616, United States
Furiex Research Site
Addison, Illinois, 60101, United States
Furiex Research Site
Chicago, Illinois, 60611, United States
Furiex Research Site
Morton, Illinois, 61550, United States
Furiex Research Site
Brownsburg, Indiana, 46112, United States
Furiex Research Site
Evansville, Indiana, 47714, United States
Furiex Research Site
Indianapolis, Indiana, 46202, United States
Furiex Research Site
Clive, Iowa, 50325, United States
Furiex Research Site
Davenport, Iowa, 52807, United States
Furiex Research Site
Iowa City, Iowa, 52242, United States
Furiex Research Site
West Des Moines, Iowa, 50266, United States
Furiex Research Site
Newton, Kansas, 67114, United States
Furiex Research Site
Prairie Village, Kansas, 66206, United States
Furiex Research Site
Shawnee Mission, Kansas, 66218, United States
Furiex Research Site
Wichita, Kansas, 67203, United States
Furiex Research Site
Wichita, Kansas, 67205, United States
Furiex Research Site
Crestview Hills, Kentucky, 41017, United States
Furiex Research Site
Hawesville, Kentucky, 42348, United States
Furiex Research Site
Lexington, Kentucky, 40509, United States
Furiex Research Site
Lexington, Kentucky, 40536, United States
Furiex Research Site
Louisville, Kentucky, 40202, United States
Furiex Research Site
Madisonville, Kentucky, 42431, United States
Furiex Research Site
Owensboro, Kentucky, 42303, United States
Furiex Research Site
Baker, Louisiana, 70794, United States
Furiex Research Site
Covington, Louisiana, 70435, United States
Furiex Research Site
Hammond, Louisiana, 70403, United States
Furiex Research Site
Metairie, Louisiana, 70006, United States
Furiex Research Site
New Orleans, Louisiana, 70124, United States
Furiex Research Site
Opelousas, Louisiana, 70570, United States
Furiex Research Site
Shreveport, Louisiana, 71101, United States
Furiex Research Site
Shreveport, Louisiana, 71105, United States
Furiex Research Site
Bangor, Maine, 04401, United States
Furiex Research Site
Annapolis, Maryland, 21401, United States
Furiex Research Site
Chevy Chase, Maryland, 20815, United States
Furiex Research Site
Brockton, Massachusetts, 02301, United States
Furiex Research Site
Watertown, Massachusetts, 02472, United States
Furiex Research Site
Ann Arbor, Michigan, 48106, United States
Furiex Research Site
Southfield, Michigan, 48034, United States
Furiex Research Site
Stevensville, Michigan, 49127, United States
Furiex Research Site
Chaska, Minnesota, 55318, United States
Furiex Research Site
Jackson, Mississippi, 39202, United States
Furiex Research Site
City of Saint Peters, Missouri, 63376, United States
Furiex Research Site
Jefferson City, Missouri, 65109, United States
Furiex Research Site
St Louis, Missouri, 63128, United States
Furiex Research Site
St Louis, Missouri, 63141, United States
Furiex Research Site
Billings, Montana, 59102, United States
Furiex Research Site
Bellevue, Nebraska, 68005, United States
Furiex Research Site
Omaha, Nebraska, 68114, United States
Furiex Research Site
Omaha, Nebraska, 68134, United States
Furiex Research Site
Las Vegas, Nevada, 89106, United States
Furiex Research Site
Las Vegas, Nevada, 89119, United States
Furiex Research Site
Collingswood, New Jersey, 08108, United States
Furiex Research Site
Edison, New Jersey, 08817, United States
Furiex Research Site
Albuquerque, New Mexico, 87106, United States
Furiex Research Site
Brooklyn, New York, 11230, United States
Furiex Research Site
Endwell, New York, 13760, United States
Furiex Research Site
Great Neck, New York, 11023, United States
Furiex Research Site
Hartsdale, New York, 10530, United States
Furiex Research Site
Kew Gardens, New York, 11415, United States
Furiex Research Site
New Windsor, New York, 12553, United States
Furiex Research Site
New York, New York, 10016, United States
Furiex Research Site
North Massapequa, New York, 11758, United States
Furiex Research Site
Poughkeepsie, New York, 12601, United States
Furiex Research Site
Asheville, North Carolina, 28801, United States
Furiex Research Site
Asheville, North Carolina, 28803, United States
Furiex Research Site
Charlotte, North Carolina, 28211, United States
Furiex Research Site
Durham, North Carolina, 27713, United States
Furiex Research Site
Fayetteville, North Carolina, 28304, United States
Furiex Research Site
Greensboro, North Carolina, 27403, United States
Furiex Research Site
Hickory, North Carolina, 28602, United States
Furiex Research Site
High Point, North Carolina, 27262, United States
Furiex Research Site
Kinston, North Carolina, 28501, United States
Furiex Research Site
Lenoir, North Carolina, 28645, United States
Furiex Research Site
Raleigh, North Carolina, 27609, United States
Furiex Research Site
Raleigh, North Carolina, 27612, United States
Furiex Research Site
Salisbury, North Carolina, 28144, United States
Furiex Research Site
Winston-Salem, North Carolina, 27103, United States
Furiex Research Site
Fargo, North Dakota, 58103, United States
Furiex Research Site
Fargo, North Dakota, 58104, United States
Furiex Research Site
Beavercreek, Ohio, 45432, United States
Furiex Research Site
Berea, Ohio, 44017, United States
Furiex Research Site
Centerville, Ohio, 45459, United States
Furiex Research Site
Cincinnati, Ohio, 45212, United States
Furiex Research Site
Cincinnati, Ohio, 45219, United States
Furiex Research Site
Columbus, Ohio, 43215, United States
Furiex Research Site
Dayton, Ohio, 45415, United States
Furiex Research Site
Dayton, Ohio, 45419, United States
Furiex Research Site
Englewood, Ohio, 45322, United States
Furiex Research Site
Franklin, Ohio, 45005, United States
Furiex Research Site
Marion, Ohio, 43302, United States
Furiex Research Site
Miamisburg, Ohio, 45342, United States
Furiex Research Site
Middleburg Heights, Ohio, 44130, United States
Furiex Research Site
Wadsworth, Ohio, 44281, United States
Furiex Research Site
Zanesville, Ohio, 43701, United States
Furiex Research Site
Tulsa, Oklahoma, 74104, United States
Furiex Research Site
Tulsa, Oklahoma, 74135, United States
Furiex Research Site
Tulsa, Oklahoma, 74136, United States
Furiex Research Site
Belle Vernon, Pennsylvania, 15012, United States
Furiex Research Site
Jenkintown, Pennsylvania, 19046, United States
Furiex Research Site
Johnstown, Pennsylvania, 15905, United States
Furiex Research Site
Lansdale, Pennsylvania, 19446, United States
Furiex Research Site
Philadelphia, Pennsylvania, 19142, United States
Furiex Research Site
Philadelphia, Pennsylvania, 19152, United States
Furiex Research Site
Pittsburgh, Pennsylvania, 15236, United States
Furiex Research Site
Pittsburgh, Pennsylvania, 15243, United States
Furiex Research Site
Uniontown, Pennsylvania, 15401, United States
Furiex Research Site
Upper Saint Clair, Pennsylvania, 15241, United States
Furiex Research Site
Cumberland, Rhode Island, 02864, United States
Furiex Research Site
East Providence, Rhode Island, 02914, United States
Furiex Research Site
Anderson, South Carolina, 29621, United States
Furiex Research Site
Charleston, South Carolina, 29406, United States
Furiex Research Site
Fort Mill, South Carolina, 29707, United States
Furiex Research Site
Greenville, South Carolina, 29615, United States
Furiex Research Site
Greer, South Carolina, 29650, United States
Furiex Research Site
Greer, South Carolina, 29651, United States
Furiex Research Site
Myrtle Beach, South Carolina, 29588, United States
Furiex Research Site
Myrtle Beach, South Carolina, 29752, United States
Furiex Research Site
Simpsonville, South Carolina, 29681, United States
Furiex Research Site
Summerville, South Carolina, 29485, United States
Furiex Research Site
Bristol, Tennessee, 37620, United States
Furiex Research Site
Chattanooga, Tennessee, 37421, United States
Furiex Research Site
Clarksville, Tennessee, 37043, United States
Furiex Research Site
Columbia, Tennessee, 38401, United States
Furiex Research Site
Franklin, Tennessee, 37064, United States
Furiex Research Site
Johnson City, Tennessee, 37604, United States
Furiex Research Site
Memphis, Tennessee, 38119, United States
Furiex Research Site
Smyrna, Tennessee, 37167, United States
Furiex Research Site
Austin, Texas, 78745, United States
Furiex Research Site
Austin, Texas, 78756, United States
Furiex Research Site
Baytown, Texas, 77521, United States
Furiex Research Site
Beaumont, Texas, 77701, United States
Furiex Research Site
Dallas, Texas, 75224, United States
Furiex Research Site
El Paso, Texas, 79905, United States
Furiex Research Site
Houston, Texas, 77074, United States
Furiex Research Site
Houston, Texas, 77079, United States
Furiex Research Site
Houston, Texas, 77089, United States
Furiex Research Site
Houston, Texas, 77098, United States
Furiex Research Site
Marshall, Texas, 75670, United States
Furiex Research Site
Plano, Texas, 75024, United States
Furiex Research Site
San Antonio, Texas, 78209, United States
Furiex Research Site
San Antonio, Texas, 78229, United States
Furiex Research Site
San Antonio, Texas, 78258, United States
Furiex Research Site
Sugar Land, Texas, 77478, United States
Furiex Research Site
Clinton, Utah, 84015, United States
Furiex Research Site
Draper, Utah, 84020, United States
Furiex Research Site
Logan, Utah, 84341, United States
Furiex Research Site
Ogden, Utah, 84405, United States
Furiex Research Site
Salt Lake City, Utah, 84102, United States
Furiex Research Site
West Jordan, Utah, 84088, United States
Furiex Research Site
Lynchburg, Virginia, 24502, United States
Furiex Research Site
Richmond, Virginia, 23219, United States
Furiex Research Site
Williamsburg, Virginia, 23185, United States
Furiex Research Site
Spokane, Washington, 99202, United States
Furiex Research Site
Spokane, Washington, 99204, United States
Furiex Research Site
Spokane, Washington, 99208, United States
Furiex Research Site
Wenatchee, Washington, 98801, United States
Furiex Research Site
Morgantown, West Virginia, 26505, United States
Furiex Research Site
Wauwatosa, Wisconsin, 53226, United States
Furiex Research Site
Kamloops, British Columbia, V2C 1K7, Canada
Furiex Research Site
Kelowna, British Columbia, V1Y 1Z9, Canada
Furiex Research Site
Winnipeg, Manitoba, R3A 1R9, Canada
Furiex Research Site
Bridgewater, Nova Scotia, B4V 3N2, Canada
Furiex Research Site
Halifax, Nova Scotia, B3K 2M5, Canada
Furiex Research Site
Cambridge, Ontario, N1S 2M6, Canada
Furiex Research Site
London, Ontario, N6A 5R8, Canada
Furiex Research Site
Niagara Falls, Ontario, L2G 1J4, Canada
Furiex Research Site
Oshawa, Ontario, L1H 1B9, Canada
Furiex Research Site
Chesterfield, Derbyshire, S40 4AA, United Kingdom
Furiex Research Site
Blackpool, Lancashire, FY3 7EN, United Kingdom
Furiex Research Site
Thornton-Cleveleys, Lancashire, FY5 3LF, United Kingdom
Furiex Research Site
Burbage, Leicestershire, LE10 2SE, United Kingdom
Furiex Research Site
Royal Leamington Spa, Warwickshire, CV32 4RA, United Kingdom
Furiex Research Site
Chippenham, Wiltshire, SN14 6GT, United Kingdom
Furiex Research Site
Bath, BA2 3HT, United Kingdom
Furiex Research Site
Bath, BA2 4BY, United Kingdom
Furiex Research Site
Coventry, CV6 4DD, United Kingdom
Furiex Research Site
Dorking, RH4 1SD, United Kingdom
Furiex Research Site
Haxey, DN9 2HY, United Kingdom
Furiex Research Site
London, E11 1NR, United Kingdom
Furiex Research Site
Shrewsbury, SY3 8XQ, United Kingdom
Furiex Research Site
Southampton, SO16 6YD, United Kingdom
Furiex Research Site
Strensall, YO32 5UA, United Kingdom
Furiex Research Site
Thornton, FY5 2TZ, United Kingdom
Furiex Research Site
Torpoint, PL11 2JW, United Kingdom
Related Publications (2)
Fant RV, Henningfield JE, Cash BD, Dove LS, Covington PS. Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea. Clin Gastroenterol Hepatol. 2017 Jul;15(7):1021-1029.e6. doi: 10.1016/j.cgh.2017.01.026. Epub 2017 Feb 3.
PMID: 28167156DERIVEDLembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA, Davenport JM, McIntyre G, Lopez R, Turner L, Covington PS. Eluxadoline for Irritable Bowel Syndrome with Diarrhea. N Engl J Med. 2016 Jan 21;374(3):242-53. doi: 10.1056/NEJMoa1505180.
PMID: 26789872DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Therapeutic Area Head
- Organization
- Allergan
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2012
First Posted
March 14, 2012
Study Start
May 29, 2012
Primary Completion
July 29, 2014
Study Completion
July 29, 2014
Last Updated
September 4, 2018
Results First Posted
September 4, 2018
Record last verified: 2018-08